Sunday April 27 at 2:00pm - 5:00pm CST Location: Poster Section 16, Poster Board Number: 13 Molecular Partners NewsMORE Related Stocks ...

March 25, 2025 (GLOBE NEWSWIRE) -- Molecular Partners AG (SIX ... or the “Company”), today announced it will hold three poster presentations at the American Association for Cancer Research ...

Update on IND-enabling data for MP0712, a Radio-DARPin targeting DLL3 and labeled with 212Pb, co-developed with Orano Med; entering FIH studies in 2025 for the treatment of small cell lung cancer Firs ...

Molecular Partners AG is a clinical-stage biotech company pioneering the design and development of DARPin therapeutics for medical challenges other drug modalities cannot readily address.

and Molecular Partners' expected business and financial outlook, including anticipated expenses and cash utilization for 2025 and its expectation of its current cash runway and the expected use of ...

ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., March 25, 2025 (GLOBE NEWSWIRE) -- Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech company developing a new class of ...